glp-1 bad breath drugs may be a of fresh air for gum bad breath on glp 1

For patients with diabetes, hypoglycemia risk increases when GLP-1 agents are combined with insulin or sulfonylureas

Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance

Although DSM-5 diagnosis is defined through multiple behavioral criteria encompassing impaired control, social dysfunction, continued use despite harm, and tolerance or withdrawal, converging clinical and preclinical evidence indicates that the core pathological feature of SUDs is the progressive loss of control over intake (O'Brien, 2005)

Ketoacidosis is a serious condition and may need to be treated in the hospital

In summary, post-therapy maintenance strategies involve self-monitoring, goal setting, and lifestyle adjustments